NCT06200883 (ENUCCI) is a Phase 4 clinical trial of Choline Bitartrate in Mild Cognitive Impairment, sponsored by Federico II University.

Who is sponsoring NCT06200883?

NCT06200883 is sponsored by Federico II University.

What drugs are being tested in NCT06200883?

Interventions in NCT06200883: Placebo oral vial, Choline Bitartrate.

What condition does NCT06200883 study?

NCT06200883 studies Mild Cognitive Impairment.

Is NCT06200883 still recruiting?

NCT06200883 is currently completed. Last updated 11 January 2024.

Last reviewed 2024-01-11 · How we verify

NCT06200883: ENUCCI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Nutraceutic Compound on Cognitive Impairment

Completed Phase 4 Last updated 11 January 2024

What this trial tests

Phase 4 trial testing Placebo oral vial in Mild Cognitive Impairment in 58 participants. Completed in 1 November 2023.

Timeline

1 September 2022

Primary endpoint
1 September 2023

1 November 2023

Quick facts

Lead sponsor	Federico II University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	58
Start date	1 September 2022
Primary completion	1 September 2023
Estimated completion	1 November 2023
Sites	1 location across Italy

Drugs / interventions tested

Placebo oral vial — full drug profile →
Choline Bitartrate — full drug profile →

Conditions studied

Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Federico II University

Who can join

40 and older, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to evaluate the effects of choline bitartrate on cognitive impairment in frailty patients. The study will analyze the impact of 4 weeks treatment randomized with a nutraceutical compound in a double-blind randomized placebo controlled trial. The investigators will also assess cognitive frailty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Choline Bitartrate

Trials testing the same drug.

NCT05108974 — Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study · Phase 2 · active not recruiting
NCT04012177 — Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial · NA · unknown
NCT03039023 — Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans · NA · completed

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting

Other Federico II University trials

Trials by the same sponsor.

NCT07437690 — Fall Prevention in Older Adults in an Italian Cohort · not yet recruiting
NCT07282132 — Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter · not yet recruiting
NCT07280286 — Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel · NA · not yet recruiting
NCT07374861 — Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy · recruiting
NCT07314684 — GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06200883 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federico II University
Last refreshed: 11 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06200883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing